Prediction and Validation of Novel BRAF Inhibitor as a Potential Drug Candidate for the Treatment of Colorectal Cancer
This work thus proposes 3-(6,7-dimethoxy-3,4-dihydroisoquinoline-2-carbonyl)-N- (2-methoxyphenyl)benzenesulphonamide as a potential BRAF V600E inhibitor for the CRC treatment.
Authors
- Sudha George Valavi (ORCID: https://orcid.org/0009-0008-4472-7937)
- Amitha Joy (ORCID: https://orcid.org/0000-0001-7535-4944)
- Amrutha Krishnan K (ORCID: https://orcid.org/0009-0009-6491-3283)
Institutions
- Kodak (France) (FR)
- APJ Abdul Kalam Technological University (IN)
- AAA College of Engineering and Technology
Publication Details
- Journal
- Current Topics in Medicinal Chemistry
- Published
- 2025-04-15
- DOI
- https://doi.org/10.2174/0115680266337334250320231553
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00